Effects of Omega-3 Supplementation on Exploratory Outcomes in the Dry Eye Assessment and Management Study
Marko Oydanich, Maureen G Maguire, Maxwell Pistilli, Pedram Hamrah, Jack V Greiner, Meng C Lin, Penny A Asbell, Dry Eye Assessment and Management Study Research Group, Marko Oydanich, Maureen G Maguire, Maxwell Pistilli, Pedram Hamrah, Jack V Greiner, Meng C Lin, Penny A Asbell, Dry Eye Assessment and Management Study Research Group
Abstract
We report results from a multicenter, randomized clinical trial (N=535) of the effect of ω-3 supplementation, relative to placebo, on exploratory and minimally invasive outcome measures for moderate to severe dry eye disease.
Figures
Mean level of continuous exploratory outcomes at baseline and through 12 months by treatment group. Red line denotes the active group and blue line denotes the placebo group. Vertical bars denote 95% confidence intervals. A) tear osmolarity; B) keratograph tear break-up time; C) tear meniscus height; and D) bulbar conjunctival redness score.
Source: PubMed